treatments because of their low side-effects on the body and the improved quality of life that they can provide. for others, alternative methods may be the patient’s “last hope” after conventional medicine failed to get rid of their cancerous tumors. here are the top 6 reasons to go ...
Top Cancer Treatments on the Way
Cancer drugs, also known as anticancer or oncology drugs, are medications, specifically designed to diagnose, treat, or manage various forms of cancer. These drugs are often used in combination with other cancer treatments such as surgery, or immunotherapy to enhance their effectiveness. These drugs...
This collection highlights our most downloaded* cancer papers published in 2022. Featuring authors from aroud the world, these papers showcase valuable research from an international community. You can also view the top papers across various subject areas here. *Data obtained from SN Insights, ...
Cancer treatments are becoming increasingly crucial in the pharmaceutical landscape. Keytruda's projected sales for 2024 underscore this trend, while the drug's revenue increased by approximately four billion dollars between 2022 and 2023. This growth is part of a larger pattern in global oncology spe...
In oncologic research and development, drugs for non-small cell lung cancer and breast cancer are among the leading diseases. On the other hand, mental health treatments generated about 36 billion dollars of revenue worldwide. One such drug is Cymbalta, manufactured by Eli Lilly and used to ...
It causes stress in your own mind and body as well as in your relationships with friends and family. Cancer treatments can make it hard to do the things you’ve always done as a human being, a parent, or an employee. There’s nothing in your daily existence that cancer doesn’t touch...
“truly innovative oncology drugs” so 2022 could see a more supportive ecosystem for the development of rare disease treatments in China. Meanwhile, they believe that me-too and me-worse drugs, which have accounted for a large portion of China’s drug market, would have a more difficult ...
10 Years in CLL: Top Advances From 2012-2022 Social Determinants of Health Should Be an Integral Component of Cancer Clinical Trials ctDNA Is Improving Oncology Care and Should Be Part of the Standard of Care Immunotherapy Hits Its Stride in Esophageal and GEJ Cancers CAR NK-Cell Therapy Is...
and HUMIRA of AbbVie, Inc., in the market space. Several studies have reported that healthcare spending on cancer treatments has doubled in the last few years. Besides, a huge number of clinical tests in immuno-oncology globally are also attributive to the largest share of the cancer ...